Molecular mechanisms of associations between abnormal differentiation and altered regulations of gene expressions.

异常分化与基因表达调节改变之间关联的分子机制。

基本信息

  • 批准号:
    18590308
  • 负责人:
  • 金额:
    $ 2.44万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

The proneural basic-helix-loop-helix protein achaete-scute homologue 1(ASH1) is expressed in a very limited spectrum in a lineage-specific manner, including normal pulmonary neuroendocrine cells and lung cancer cells with neuroendocrine features. Our previous results indicated that ASH1 may play a crucial role in the growth and survival of lung cancers with neuroendocrine features. In the present study, we report for the first time that ASH1 functions as a dual transcription factor by activating neuroendocrine differentiation markers and also repressing putative tumor suppressors. This protein was found to inactivate DKK1 and DKK3, negative regulators of Wnt/β-catenin signaling, E-cadherin, and integrinβ1 through ASH 1-mediated deacetylation and repressive trimethylation of lysine 27(H3K27me3) of histone H3 in the promoter regions of DKK1 and E-cadherin. Our results provide important clues for a better understanding of the molecular and cellular biological roles of ASH1 in the process … More of carcinogenesis of lung cancers with neuroendocrine features and warrant future investigations to shed light on the lineage-specific dependency of this transcription factor with dual functions.We previously reported the amplification and overexpression of the miR-17-92 microRNAs(miRNA) cluster at 13q31.3 in lung cancers. In the present study, we show that inhibition of miR-17-5p and miR-20a with antisense oligonucleotides can induce apoptosis selectively in lung cancer cells overexpressing miR-17-92, suggesting the possibility of 'OncomiR addiction' to expression of these miRNAs in a subset of lung cancers. During the course of this study, we also found that enforced expression of a genomic region, termed C2, residing 3' to miR-17-92 in the intron 3 of C13orf25 led to marked growth inhibition in association with double stranded RNA-dependent protein kinase activation. Taken together, the present findings contribute towards better understanding of the oncogenic roles of miR-17-92, which might ultimately lead to the future translation into clinical applications. Less
前神经碱性螺旋环螺旋蛋白无毛鳞片同源物1(ASH 1)以谱系特异性方式在非常有限的谱中表达,包括正常肺神经内分泌细胞和具有神经内分泌特征的肺癌细胞。我们以前的研究结果表明,ASH 1可能在具有神经内分泌特征的肺癌的生长和生存中起着至关重要的作用。在本研究中,我们首次报道了ASH 1作为一种双重转录因子,通过激活神经内分泌分化标志物和抑制假定的肿瘤抑制因子发挥作用。发现该蛋白通过ASH 1介导的DKK 1和E-cadherin启动子区域中组蛋白H3的赖氨酸27(H3 K27 me 3)的脱乙酰化和抑制性三甲基化来抑制Wnt/β-catenin信号传导、E-cadherin和整合素β1的负调节因子DKK 1和DKK 3。我们的研究结果为更好地理解ASH 1在此过程中的分子和细胞生物学作用提供了重要线索 ...更多信息 我们先前报道了在肺癌中13q31.3的miR-17-92 microRNA(miRNA)簇的扩增和过表达。在本研究中,我们发现,用反义寡核苷酸抑制miR-17- 5 p和miR-20 a可以选择性地诱导过表达miR-17-92的肺癌细胞凋亡,这表明在肺癌的一个子集中,这些miRNA的表达可能存在“OncomiR成瘾”。在本研究过程中,我们还发现,位于C13 orf 25内含子3中miR-17-92 3'端的基因组区域(称为C2)的强制表达导致与双链RNA依赖性蛋白激酶激活相关的显著生长抑制。总之,目前的研究结果有助于更好地理解miR-17-92的致癌作用,这可能最终导致未来转化为临床应用。少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ASH1 gene may be prototypic "lineage-survival oncogene" and specific therapeutic target for lung cancers with neuroendocrine features.
ASH1基因可能是典型的“谱系生存癌基因”,也是具有神经内分泌特征的肺癌的特异性治疗靶点。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Osada H;et. al.
  • 通讯作者:
    et. al.
Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer
  • DOI:
    10.1158/0008-5472.can-07-5039
  • 发表时间:
    2008-03-15
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    Osada, Hirotaka;Tomida, Shuta;Takahashi, Takashi
  • 通讯作者:
    Takahashi, Takashi
Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors
  • DOI:
    10.1200/jco.2005.03.8224
  • 发表时间:
    2006-04-10
  • 期刊:
  • 影响因子:
    45.3
  • 作者:
    Takeuchi, T;Tomida, S;Takahashi, T
  • 通讯作者:
    Takahashi, T
The ASH1 Gene may be a Prototypic "Lineage-Survival Oncogene" and a Specific the Rapeutic Target for Lung Cancers with Neuroendocrine Features.
ASH1基因可能是一种原型“谱系生存癌基因”,也是具有神经内分泌特征的肺癌的特定治疗靶点。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Osada H;et. al.;Osada H;Osada H.
  • 通讯作者:
    Osada H.
ASH1 induces neuroendocrine differentiation and represses DKK1, an inhibitor of Wnt signaling.
ASH1 诱导神经内分泌分化并抑制 DKK1(Wnt 信号传导抑制剂)。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Osada H;Tatematsu Y;Takeuchi T;Tomida S;Yatabe Y;Mitsudomi T;Sekido Y;Takahashi T.
  • 通讯作者:
    Takahashi T.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OSADA Hirotaka其他文献

OSADA Hirotaka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OSADA Hirotaka', 18)}}的其他基金

Cell lineage-related mechanisms involved in lung cancer stem cell development.
肺癌干细胞发育中涉及的细胞谱系相关机制。
  • 批准号:
    23501281
  • 财政年份:
    2011
  • 资助金额:
    $ 2.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of epigenetic abnormalities involved in lung cancer progression.
肺癌进展中涉及的表观遗传异常的研究。
  • 批准号:
    20590324
  • 财政年份:
    2008
  • 资助金额:
    $ 2.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Alterations of Genome Network Regulations and Chromatin Configurations related to Carcinogenesis
与癌发生相关的基因组网络调控和染色质构型的改变
  • 批准号:
    16590258
  • 财政年份:
    2004
  • 资助金额:
    $ 2.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The mechanism of apoptosis induction by TGF-β stimuli and its clinical application
TGF-β刺激诱导细胞凋亡的机制及其临床应用
  • 批准号:
    13670157
  • 财政年份:
    2001
  • 资助金额:
    $ 2.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Involvement of LIM domain proteins and Lbd2 in the lung tissue development and carcinogensis.
LIM 结构域蛋白和 Lbd2 参与肺组织发育和致癌作用。
  • 批准号:
    11670158
  • 财政年份:
    1999
  • 资助金额:
    $ 2.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional Characterization of LIMK2 carrying LIM and PDZ Domains in the Developmental and Tumorigenic Process.
携带 LIM 和 PDZ 结构域的 LIMK2 在发育和致瘤过程中的功能表征。
  • 批准号:
    09670170
  • 财政年份:
    1997
  • 资助金额:
    $ 2.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Identifying strategies to therapeutically target the unique epigenetic landscape of small cell lung cancer
确定针对小细胞肺癌独特表观遗传景观的治疗策略
  • 批准号:
    490137
  • 财政年份:
    2023
  • 资助金额:
    $ 2.44万
  • 项目类别:
    Operating Grants
Cell-of-Origin Footprints of Passenger Mutations in Human Lung Cancer
人类肺癌中乘客突变的细胞起源足迹
  • 批准号:
    10871512
  • 财政年份:
    2023
  • 资助金额:
    $ 2.44万
  • 项目类别:
Mechanisms by which LSD1 Promotes Neuroendocrine Differentiation and Small Cell Lung Cancer
LSD1促进神经内分泌分化和小细胞肺癌的机制
  • 批准号:
    10584661
  • 财政年份:
    2022
  • 资助金额:
    $ 2.44万
  • 项目类别:
Uncovering Epigenetic and Transcriptional Drivers of Neuroendocrine Plasticity at Single-Cell Level in Patients with Small Cell Lung Cancer Transformation
在单细胞水平上揭示小细胞肺癌转化患者神经内分泌可塑性的表观遗传和转录驱动因素
  • 批准号:
    10540383
  • 财政年份:
    2021
  • 资助金额:
    $ 2.44万
  • 项目类别:
Uncovering Epigenetic and Transcriptional Drivers of Neuroendocrine Plasticity at Single-Cell Level in Patients with Small Cell Lung Cancer Transformation
在单细胞水平上揭示小细胞肺癌转化患者神经内分泌可塑性的表观遗传和转录驱动因素
  • 批准号:
    10370691
  • 财政年份:
    2021
  • 资助金额:
    $ 2.44万
  • 项目类别:
Cell-of-Origin Footprints of Passenger Mutations in Human Lung Cancer
人类肺癌中乘客突变的细胞起源足迹
  • 批准号:
    10493209
  • 财政年份:
    2021
  • 资助金额:
    $ 2.44万
  • 项目类别:
Cell-of-Origin Footprints of Passenger Mutations in Human Lung Cancer
人类肺癌中乘客突变的细胞起源足迹
  • 批准号:
    10299387
  • 财政年份:
    2021
  • 资助金额:
    $ 2.44万
  • 项目类别:
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors
研究 Max 作为小细胞肺癌和其他神经内分泌肿瘤的抑癌基因
  • 批准号:
    10662195
  • 财政年份:
    2020
  • 资助金额:
    $ 2.44万
  • 项目类别:
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors
研究 Max 作为小细胞肺癌和其他神经内分泌肿瘤的抑癌基因
  • 批准号:
    10400844
  • 财政年份:
    2020
  • 资助金额:
    $ 2.44万
  • 项目类别:
Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer
在小细胞肺癌簇细胞变体中利用 POU2F3 成瘾
  • 批准号:
    10221648
  • 财政年份:
    2019
  • 资助金额:
    $ 2.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了